TissueEngineering & Biomaterials
Institute of Applied Medical Engineering
Director: Univ.-Prof. Dr. med. Dipl.-Ing. Thomas Schmitz Rode
Helmholtz Institute of RWTH Aachen University & Hospital

Head


Univ.-Prof. Dr. med.

Stefan Jockenhoevel

Phone AME: +49 (0) 241 80 89886

Phone ITA: +49 (0) 241 80 23401

 
Email

 

 

News


UROP Stipendium für David Bürgerhausen

Undergraduate Research Opportunities Program

 

Read about Professor Jockenhövel's talk to Childern at the "Kids-University".

 


Tissue Engineering


The goal of Cardiovascular Tissue Engineering is the cultivation of completely autologous cardiovascular implants. Figure 1 illustrates the manufacturing principle of such an autologous heart valve, for example, on the basis of a fibrin gel scaffold. From a biopsy (vein, artery, umbilical cord), the intended cell sources are isolated and cultivated. In parallel, the fibrin gel components are also isolated from a patient’s blood sample.

Figure 1: Principle of heart valve construction based on an autolgous fibrin gel matrix

In an injection moulding procedure, a tricuspid heart valve is manufactured from the structural cells (myofibroblasts) and the fibrin gel matrix. The heart valve is subsequently “conditioned” in a bioreactor system in order to form a stable, implantable structure.

In a second step, the surface of the valve is coated with an endothelial cell lining using dynamic cultivation in a bioreactor.

A completely autologous heart valve results at the end of the manufacturing process, which can subsequently be (re)implanted into the patient.

 
Top Top